Streetbeat News

Earnings

SCS

Steelcase reported mixed Q4 financial results and provided Q1 revenue guidance that fell below market expectations, leading to a decline in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:39 pm

EPAC

Enerpac Tool Group (NYSE:EPAC) reported its Q2 earnings, missing estimated earnings by 0.0% with an EPS of $0.36, and a revenue decrease of $3.52 million from the previous year. Last quarter, the company beat EPS estimates which led to a 2.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 8:35 pm

VOR

Vor Biopharma anticipates releasing additional data on engraftment and protection from its VBP101 clinical trial in the second half of 2024. This update is crucial for investors monitoring the progress of Vor Biopharma's key clinical developments.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:34 pm

CHWY

Chewy Inc (NYSE:CHWY) reported Q4 net sales of $2.83 billion, a 4.2% increase year-over-year, surpassing the consensus estimate of $2.79 billion. Adjusted EPS was 18 cents, beating the expected loss of 4 cents per share. Full-year sales were $11.15 billion, up 10.2%. CEO Sumit Singh highlighted market share gains, margin expansion, and accelerated free cash flow. For Q1, revenue is expected between $2.84 billion and $2.86 billion, with fiscal 2024 projections of $11.6 to $11.8 billion, above consensus estimates of $11.12 billion. After the announcement, CHWY shares rose 6% in after-hours trading.

Portfolio Pulse from Chris Katje

March 20, 2024 | 8:33 pm

CAAP

Corporacion America (NYSE:CAAP) reported Q4 earnings of $0.81 per share, surpassing the $0.29 estimate, marking a 912.5% increase from last year. However, its Q4 sales of $365M fell short of the $431.1M estimate, a 5.54% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:33 pm

EPAC

Enerpac Tool Group has confirmed its fiscal year 2024 net sales forecast to be in the range of $590 million to $605 million, aligning closely with the market estimate of $602 million.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:32 pm

EPAC

Enerpac Tool Group (EPAC) reported Q2 2024 earnings of $0.36 per share, meeting analyst estimates. However, their quarterly sales of $138.4M fell short of the expected $141.1M, marking a 1.91% miss and a 2.51% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:31 pm

VOR

Vor Biopharma (NASDAQ:VOR) reported a Q4 2023 GAAP EPS of $(0.39), surpassing the analyst consensus estimate of $(0.51) by 23.53%.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:30 pm

NCNA

NuCana anticipates announcing data from the Phase 2 part of its Phase 1/2 study of NUC-7738 in combination with Pembrolizumab for melanoma treatment in FY24.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:27 pm

GES

Guess? Inc. (GES) shares surged following the announcement of its Q4 financial results, which exceeded expectations. Additionally, the company declared a special dividend of $2.25 per share.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:26 pm